Genenta Science S.p.A.
GNTA
$1.60
-$0.20-11.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | -12.75% | -15.04% | -17.94% | -24.57% | 2.90% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | -32.95% | -34.71% | -21.05% | -27.42% | 5.30% |
| Operating Income | 32.95% | 34.71% | 21.05% | 27.42% | -5.30% |
| Income Before Tax | 39.43% | 41.02% | 0.09% | 8.15% | 1.23% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | 39.43% | 41.02% | 0.09% | 8.15% | 1.23% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 39.43% | 41.02% | 0.09% | 8.15% | 1.23% |
| EBIT | 32.95% | 34.71% | 21.05% | 27.42% | -5.30% |
| EBITDA | 32.97% | 34.72% | 20.99% | 27.36% | -5.31% |
| EPS Basic | 46.34% | 47.78% | 2.77% | 10.66% | 1.66% |
| Normalized Basic EPS | 46.40% | 47.76% | 2.82% | 10.53% | 1.55% |
| EPS Diluted | 46.34% | 47.78% | 2.77% | 10.66% | 1.66% |
| Normalized Diluted EPS | 46.40% | 47.76% | 2.82% | 10.53% | 1.55% |
| Average Basic Shares Outstanding | 12.91% | 12.91% | 2.80% | 2.80% | 0.40% |
| Average Diluted Shares Outstanding | 12.91% | 12.91% | 2.80% | 2.80% | 0.40% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |